37 related articles for article (PubMed ID: 23661456)
1. HNF1B and JAZF1 genes, diabetes, and prostate cancer risk.
Stevens VL; Ahn J; Sun J; Jacobs EJ; Moore SC; Patel AV; Berndt SI; Albanes D; Hayes RB
Prostate; 2010 May; 70(6):601-7. PubMed ID: 19998368
[TBL] [Abstract][Full Text] [Related]
2. Stoichiometric gene-to-reaction associations enhance model-driven analysis performance: Metabolic response to chronic exposure to Aldrin in prostate cancer.
Marín de Mas I; Torrents L; Bedia C; Nielsen LK; Cascante M; Tauler R
BMC Genomics; 2019 Aug; 20(1):652. PubMed ID: 31416420
[TBL] [Abstract][Full Text] [Related]
3. HNF1B variants associate with promoter methylation and regulate gene networks activated in prostate and ovarian cancer.
Ross-Adams H; Ball S; Lawrenson K; Halim S; Russell R; Wells C; Strand SH; Ørntoft TF; Larson M; Armasu S; Massie CE; Asim M; Mortensen MM; Borre M; Woodfine K; Warren AY; Lamb AD; Kay J; Whitaker H; Ramos-Montoya A; Murrell A; Sørensen KD; Fridley BL; Goode EL; Gayther SA; Masters J; Neal DE; Mills IG
Oncotarget; 2016 Nov; 7(46):74734-74746. PubMed ID: 27732966
[TBL] [Abstract][Full Text] [Related]
4. Primary Clear Cell Carcinoma of the Pancreas: A Systematic Review.
Tannous T; Perez Rodriguez AL; Mak AW; Tannous K; Keating M
Cureus; 2021 Jun; 13(6):e15668. PubMed ID: 34150416
[TBL] [Abstract][Full Text] [Related]
5. Hepatocyte nuclear factor 1 beta: A perspective in cancer.
Chandra S; Srinivasan S; Batra J
Cancer Med; 2021 Mar; 10(5):1791-1804. PubMed ID: 33580750
[TBL] [Abstract][Full Text] [Related]
6. A Large-Scale Association Study Detects Novel Rare Variants, Risk Genes, Functional Elements, and Polygenic Architecture of Prostate Cancer Susceptibility.
Emami NC; Cavazos TB; Rashkin SR; Cario CL; Graff RE; Tai CG; Mefford JA; Kachuri L; Wan E; Wong S; Aaronson D; Presti J; Habel LA; Shan J; Ranatunga DK; Chao CR; Ghai NR; Jorgenson E; Sakoda LC; Kvale MN; Kwok PY; Schaefer C; Risch N; Hoffmann TJ; Van Den Eeden SK; Witte JS
Cancer Res; 2021 Apr; 81(7):1695-1703. PubMed ID: 33293427
[TBL] [Abstract][Full Text] [Related]
7. Influences of TP53 and the anti-aging DDR1 receptor in controlling Raf/MEK/ERK and PI3K/Akt expression and chemotherapeutic drug sensitivity in prostate cancer cell lines.
Chappell WH; Candido S; Abrams SL; Akula SM; Steelman LS; Martelli AM; Ratti S; Cocco L; Cervello M; Montalto G; Nicoletti F; Libra M; McCubrey JA
Aging (Albany NY); 2020 Jun; 12(11):10194-10210. PubMed ID: 32492656
[TBL] [Abstract][Full Text] [Related]
8. DNA methylation and cis-regulation of gene expression by prostate cancer risk SNPs.
Dai JY; Wang X; Wang B; Sun W; Jordahl KM; Kolb S; Nyame YA; Wright JL; Ostrander EA; Feng Z; Stanford JL
PLoS Genet; 2020 Mar; 16(3):e1008667. PubMed ID: 32226005
[TBL] [Abstract][Full Text] [Related]
9. HNF1B expression regulates ECI2 gene expression, potentially serving a role in prostate cancer progression.
Dan C; Zhang H; Zeng W; Huang L; Gong X; Li H; Yang E; Wang L; Yao Q
Oncol Lett; 2019 Jan; 17(1):1094-1100. PubMed ID: 30655870
[TBL] [Abstract][Full Text] [Related]
10. Nur77 suppression facilitates androgen deprivation-induced cell invasion of prostate cancer cells mediated by TGF-β signaling.
Wu J; Sun H; Yang X; Sun X
Clin Transl Oncol; 2018 Oct; 20(10):1302-1313. PubMed ID: 29594945
[TBL] [Abstract][Full Text] [Related]
11. Network-directed cis-mediator analysis of normal prostate tissue expression profiles reveals downstream regulatory associations of prostate cancer susceptibility loci.
Larson NB; McDonnell SK; Fogarty Z; Larson MC; Cheville J; Riska S; Baheti S; Weber AM; Nair AA; Wang L; O'Brien D; Davila J; Schaid DJ; Thibodeau SN
Oncotarget; 2017 Oct; 8(49):85896-85908. PubMed ID: 29156765
[TBL] [Abstract][Full Text] [Related]
12. A review on hepatocyte nuclear factor-1beta and tumor.
Yu DD; Guo SW; Jing YY; Dong YL; Wei LX
Cell Biosci; 2015; 5():58. PubMed ID: 26464794
[TBL] [Abstract][Full Text] [Related]
13. Overexpression Of Hepatocyte Nuclear Factor-1beta Predicting Poor Prognosis Is Associated With Biliary Phenotype In Patients With Hepatocellular Carcinoma.
Yu DD; Jing YY; Guo SW; Ye F; Lu W; Li Q; Dong YL; Gao L; Yang YT; Yang Y; Wu MC; Wei LX
Sci Rep; 2015 Aug; 5():13319. PubMed ID: 26311117
[TBL] [Abstract][Full Text] [Related]
14. Selecting causal genes from genome-wide association studies via functionally coherent subnetworks.
Taşan M; Musso G; Hao T; Vidal M; MacRae CA; Roth FP
Nat Methods; 2015 Feb; 12(2):154-9. PubMed ID: 25532137
[TBL] [Abstract][Full Text] [Related]
15. Expression of bile duct transcription factor HNF1β predicts early tumor recurrence and is a stage-independent prognostic factor in hepatocellular carcinoma.
Yuan RH; Lai HS; Hsu HC; Lai PL; Jeng YM
J Gastrointest Surg; 2014 Oct; 18(10):1784-94. PubMed ID: 25052070
[TBL] [Abstract][Full Text] [Related]
16. Association of a single-nucleotide polymorphism from chromosome 17q12 with the aggressiveness of prostate cancer in a Hispanic population.
Rojas PA; Torres-Estay V; Cerda-Infante J; Montecinos VP; Domínguez J; Arenas J; Godoy AS; San Francisco IF
J Cancer Res Clin Oncol; 2014 May; 140(5):783-8. PubMed ID: 24627192
[TBL] [Abstract][Full Text] [Related]
17. HNF1b is involved in prostate cancer risk via modulating androgenic hormone effects and coordination with other genes.
Hu YL; Zhong D; Pang F; Ning QY; Zhang YY; Li G; Wu JZ; Mo ZN
Genet Mol Res; 2013 Apr; 12(2):1327-35. PubMed ID: 23661456
[TBL] [Abstract][Full Text] [Related]
18. Rap2 regulates androgen sensitivity in human prostate cancer cells.
Bigler D; Gioeli D; Conaway MR; Weber MJ; Theodorescu D
Prostate; 2007 Oct; 67(14):1590-9. PubMed ID: 17918750
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
